Going into FY2022, Lam has raised his topline estimates for the year by 4.4% as he expects sales to remain elevated, driven by demand.
SAC Capital analyst Lam Wang Kwan is remaining buoyant on Megachem with a “buy” call after the chemicals company saw a record year.
For the FY2021 ended December, Megachem saw its topline grow 32.0% y-o-y to $140.3 million, while its bottom line surged 52.0% y-o-y to $8.0 million, surpassing Lam’s full-year forecasts by 5.4% and 25.0% respectively.
